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Aim:	 Spinal	 ependymomas	 are	 among	 the	 most	 common	 intramedullary	
neoplasms	 in	 both	 adults	 and	 children.	 While	 surgical	 resection	 is	 the	 golden	
treatment	 standard,	 the	 role	 chemotherapy	 and	 radiotherapy	 have	 in	 patients	
with	 spinal	 ependymomas	 remains	 unclear.	The	 aim	of	 this	 study	 is	 to	 determine	
the	 predictors	 of	 functional	 outcome	 following	 spinal	 ependymoma	 resection	 to	
single	 out	 patients	 that	 may	 require	 adjuvant	 therapy.	 Methods:	 We	 conducted	
a	 retrospective	 study	 on	 patients	 that	 underwent	 spinal	 ependymoma	 resection	
in	 our	 institution	 in	 a	 10‑year	 period.	 Magnetic	 resonance	 imaging	 of	 the	
spine	 was	 used	 to	 set	 the	 diagnosis	 of	 an	 intradural/intramedullary	 neoplasm.	
All	 patients	 underwent	 either	 gross	 tumor	 resection	 or	 tumor	 mass	 reduction.	
Histological	 diagnosis	 and	 histopathological	 grading	 of	 spinal	 ependymoma	were	
done	 for	 all	 collected	 samples.	 Patients’	 general	 and	 neurological	 examination	
were	 performed	 early	 after	 the	 surgery	 (within	 the	 1st	 week)	 and	 in	 a	 6‑month	
follow‑up.	 Results:	 A	 total	 of	 51	 intradural	 and	 intramedullary	 ependymoma	
resection	surgeries	on	43	patients	were	performed.	There	were	slightly	more	male	
patients	(57%)	and	the	average	patient	age	was	41	years.	About	76.5%	of	patients	
presented	with	 a	 tumor	affecting	one	vertebrae	 level,	while	23.5%	presented	with	
tumors	 expanding	 over	 two	 or	 more	 spinal	 regions.	 Gross	 tumor	 resection	 was	
achieved	in	80%	of	cases,	while	25%	of	procedures	were	performed	on	a	recurring	
ependymomas.	Most	of	the	tumors	(57%)	were	classified	as	G2	histological	grade,	
while	 8%	 were	 anaplastic	 ependymomas.	 In	 80%	 of	 cases,	 early	 postoperative	
patient	 status	 was	 either	 better	 or	 equivalent	 to	 the	 preoperative	 one,	 while	 in	 a	
6‑month	 follow‑up,	 up	 to	 60%	 of	 cases	 showed	 a	 significant	 improvement	 over	
the	 preoperative	 status.	 Different	 demographic	 and	 clinical	 parameters	 were	 not	
proven	to	be	predictors	of	postsurgical	patient	outcome	including	age,	gender,	and	
initial	neurological	presentation.	Interestingly,	most	tumor	characteristics	were	also	
not	 associated	with	 postoperative	 functional	 outcome	 (histological	 grade,	 number	
of	 vertebrae	 levels	 affected,	 whether	 it	 is	 a	 primary	 or	 recurrent	 tumor).	 Even	
the	 scope	 of	 surgical	 procedure	 did	 not	 affect	 the	 functional	 outcome.	The	 spinal	
region	 affected	 by	 the	 tumor	was	 proven	 to	 be	 a	 predictor	 of	 early	 postoperative	
outcome	(ρ	=	0.346, P =	0.033),	with	lumbar	spine	being	associated	with	the	best	
outcomes.	As	expected,	the	scope	of	the	surgery	and	whether	gross	tumor	resection	
or	 tumor	 mass	 reduction	 was	 performed	 were	 the	 only	 significant	 predictors	 of	
tumor	 recurrence	 (ρ	 =	 0.391, P =	 0.005).	 Conclusions:	 Spinal	 ependymoma	
resection	 is	 an	 efficient	 procedure	 that	 improves	 the	 patient	 outcomes.	 Spinal	
region	 affected	 by	 the	 tumor	 is	 likely	 to	 be	 the	 most	 important	 predictor	 of	
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Introduction
Spinal	 ependymomas	 are	 benign,	 slow‑growing	 spinal	cord	 tumors	 that	 develop	 from	 ependymal	 cells	 and	
the	 adjacent	 tissues.[1,2]	 They	 are	 the	 most	 common	
intramedullary	 spinal	 cord	 neoplasms	 in	 adults	 and	 the	
second	 most	 common	 in	 children.[1‑4]	 Although	 being	
such	 a	 prominent	 epidemiologic	 issue,	 our	 existing	
knowledge	 concerning	 their	 treatment	 modalities	 and	
prognostic	 factors	 remains	 sparse.	 Due	 to	 the	 benign	
nature	 of	 spinal	 ependymomas,	 surgical	 resection	 is	
deemed	to	be	the	golden	treatment	standard.[5‑14]	However,	
the	role	chemotherapy	and	radiotherapy	have	 in	patients	
with	spinal	ependymomas	remains	unclear.[1‑14]	Thus,	the	
importance	 lays	 in	 the	 proper	 recognition	 of	 outcome	
predictors	 that	 can	 be	 used	 to	 single	 out	 patients	 with	
worse	 functional	 outcome,	 higher	 risk	 of	 recurrence,	
and	 a	 lower	 overall	 survival	 that	 may	 require	 adjuvant	
therapy.
Aims
Our	aim	was	to	detect	the	best	predictors	of	postoperative	
functional	outcome	as	well	as	to	determine	the	predictors	
of	 tumor	 recurrence	 in	a	 retrospective	cohort	of	patients	
with	spinal	ependymomas	treated	at	our	center.
Methods
We	 performed	 a	 single‑center	 retrospective	 analysis	
of	 patients	 treated	 for	 spinal	 ependymomas	 at	 our	
department	(Department	of	Neurosurgery,	UHC	Zagreb),	
during	 a	 10‑year	 period	 (from	 2006	 to	 2016).	 A	 total	
of	 43	 patients	 (average	 age	 41,	 age	 span	 16–76	 years,	
43%	 female)	 [Figure	 1]	 diagnosed	 with	 intradural	 and	
intramedullary	spinal	neoplasm	using	magnetic	resonance	
imaging,	 underwent	 a	 total	 of	 51	 surgical	 removal	
procedures.	 Surgical	 treatment	 included	 laminotomy	 or	
laminectomy,	 durotomy,	 midline	 myelotomy,	 dissection	
and	debulking	of	 tumor,	 and	gross	 total	 tumor	 resection	
or	tumor	mass	reduction.	All	procedures	were	performed	
using	 intraoperative	 neurophysiological	 monitoring.	
Histological	 diagnosis	 and	 histopathological	 grading	
of	 spinal	 ependymoma	 were	 done	 for	 all	 the	 collected	
samples.	 Follow‑up	 evaluation	 was	 performed	 early	
after	 surgery	 and	 in	 a	 3–6‑month	 period.	 Each	 patient	
underwent	 extensive	 physical	 and	 neurological	
examination	 to	 adequately	 assess	 their	 early	 and	
late	 postoperative	 functional	 recovery.	 Statistical	
analysis	 included	 group	 comparison	 (Chi‑square	 test),	
correlational	 analysis	 (Spearman	 coefficient),	 and	
univariate	 regression	 analysis. P <	 0.05	was	 considered	
statistically	 significant	 and	 SPSS	 version	 21	 software	
(IBM	Corporation,	USA)	was	used.
All	 phases	 of	 this	 study	 were	 performed	 in	 accordance	
with	 the	 World	 Medical	 Association	 Declaration	 of	
Helsinki	 –	 Ethical	 principles	 for	 medical	 research	
involving	human	subjects.
Results
When	 considering	 tumor	 characteristics,	 almost	 three	
quarters	 of	 all	 patients	 presented	with	 a	 tumor	 affecting	
only	 one	 vertebral	 level	 (mostly	 lumbar),	while	 the	 rest	
presented	 with	 a	 tumor	 expanding	 over	 two	 or	 more	
spinal	 regions	 (mostly	 lumbar	 and	 thoracic)	 [Figure	 2].	
In	 addition,	 two‑thirds	 of	 the	 patients	 presented	 with	
a	 tumor	 affecting	 one	 or	 two	 vertebrae	 [Figure	 3].	
Pathohistology	 revealed	 most	 of	 the	 tumors	 to	 be	
G2	 histological	 grade	 (57%)	 with	 a	 third	 being	
myxopapillary	 ependymomas,	 and	 8%	 being	 anaplastic	
ependymomas	[Figure	4].
As	 for	 surgical	 removal	 procedures,	 in	 most	 of	 the	
cases	 (over	 80%),	 gross	 total	 tumor	 resection	 was	
achieved	 [Figure	 5],	with	 a	 quarter	 of	 procedures	 being	
performed	on	recurrent	tumors.
Early	 postoperative	 neurologic	 status	 was	 either	 better	
or	 equivalent	 to	 the	 preoperative	 one	 in	 over	 80%	
of	 patients	 [Figure	 6],	 with	 60%	 of	 patients	 showing	
a	 significant	 improvement	 in	 a	 6‑month	 follow‑up	
period	[Figure	7].
When	 dividing	 the	 patients	 into	 groups	 according	 to	
early	 and	 late	 postoperative	 outcomes,	 neither	 age	 nor	
gender	was	 associated	with	 a	worse	 outcome	 [Table	 1].	
Interestingly,	 both	 the	 size	 of	 the	 tumor	 (measured	 as	
a	 number	 of	 affected	 vertebrae	 and	 spinal	 regions)	 and	
the	histological	grade	were	not	found	to	be	predictive	of	
adverse	 outcome	 (worse	 neurological	 status)	 [Table	 1].	
This	 was	 also	 the	 case	 with	 the	 extent	 of	 the	 surgical	
procedure	 (gross	 tumor	 resection	 or	 tumor	 mass	
reduction)	and	whether	it	was	a	procedure	on	a	recurrent	
tumor	or	not	 [Table	1].	These	results	were	same	in	both	
early	and	late	postoperative	period	[Table	1].
The	 only	 significant	 predictor	 of	 a	 good	 outcome	
was	 the	 spinal	 region	 affected	 with	 the	 tumor,	 with	
lumbar	 region	 being	 associated	 with	 best	 early	
functional	 outcome,	 while	 the	 procedure	 scope	 seems	 to	 be	 the	most	 important	
predictor	of	tumor	recurrence.
Keywords: Functional outcome, gross total tumor resection, predictors, spinal 
ependymoma, tumor recurrence
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outcomes	 (ρ	 =	 0.346, P =	 0.033).	As	 it	 was	 expected,	
early	 outcomes	 correlated	 significantly	 with	 late	
outcomes	(ρ	=	0.273, P =	0.042).
Similarly	 to	 outcome	 analysis	 neither	 the	 tumor	 size	 nor	
the	 histological	 grade	was	 found	 to	 correlate	with	 tumor	
recurrence	 in	 our	 small	 cohort	 of	 patients	 [Table	 2].	
However,	 the	 extent	 of	 surgical	 procedure	 was	
significantly	associated	with	tumor	recurrence	(ρ	=	0.391, 
P =	0.005).	In	addition,	a	trend	between	younger	age,	male	
gender,	 and	 tumor	 recurrence	was	 detected	 (ρ	 =	 −0.232, 
P =	0.100;	ρ	=0.237, P =	0.094,	respectively).
Discussion
Although	 being	 a	 prominent	 neuroepidemiologic	
issue,	 especially	 among	 the	 younger	 population,	 spinal	
ependymoma	 incidence	 (and	 prevalence)	 remains	
relatively	 low	(1–2	per	one	million	people,	per	year).[1‑4]	
This	 is	 in	 accordance	 with	 Croatian	 registries	 and	 our	
Center	data.	In	addition,	the	average	patient	presentation	
age	 in	 our	 population	 is	 similar	 to	 the	 data	 presented	
by	 other	 researchers.[1‑14]	 Nearly,	 equal	 gender	
distribution	 (shown	by	 different	 registries)	was	 detected	
in	our	population	too.[1‑14]
Histological	 analysis	 showed	 that	 most	 of	 the	
tumors	 in	 our	 patient	 cohort	 to	 be	 low	 malignant	
ependymomas	 (G2	 grade).	 Only	 one‑third	 of	
the	 patients	 presented	 with	 a	 benign	 (Grade	 I)	
Figure 4:	Patient	distribution	according	pathohistological	grade	of	spinal	
ependymoma	tissue
Figure 5:	Distribution	 according	 to	 the	 achieved	 scope	 of	 surgical	
procedure
Figure 6:	Early	postoperative	functional	status
Figure 1:	Patient	gender	distribution
Figure 2:	Patient	distribution	according	 to	 spinal	 regions	 affected	by	
spinal	ependymoma
Figure 3:	Patient	distribution	according	to	number	of	vertebrae	affected	
by	spinal	ependymoma
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ependymoma	 interestingly,	 all	 of	 them	 being	
myxopapillary	 tumors.	 The	 prevalence	 of	 high	
malignant	ependymomas	in	our	cohort	was	<1:12.	The	
specific	 tumor	 distribution	 in	 our	 patient	 population	
can	 be	 due	 to	 the	 study	 inclusion	 bias	 (symptomatic	
patients	 undergoing	 surgical	 removal).	 However,	 the	
influence	 of	 unknown	 (genetic	 and	 environmental)	
features	 of	 Croatian	 population	 cannot	 be	 excluded	
from	 the	 study.	 A	 troublesome	 observation	 is	 that	
data	 on	 histological	 distribution	 of	 ependymomas	 in	
different	populations	remain	sparse.
Most	of	our	patients	presented	with	a	 tumor	expanding	
over	 two	 vertebrae	 levels;	 however,	 the	 majority	
being	 contained	 within	 a	 single	 spinal	 region	 (mostly	
lumbar).	 This	 is	 probably	 also	 due	 to	 the	 study	
inclusion	 criteria,	which	 targeted	 symptomatic	 patients	
undergoing	surgical	removal.
Although	 the	 aim	 of	 this	 study	 was	 not	 to	 evaluate	
the	 survival	 of	 our	 patient	 cohort	 (mostly	 due	 to	 a	
short	 follow‑up	 period),	 it	 is	 interesting	 to	 notice	 that	
6	 months	 survival	 was	 100%	 in	 a	 population	 with	
over	60%	of	malignant	ependymomas.
The	 completeness	 of	 tumor	 resection,	 localization,	
WHO	grade,	age,	extent	of	the	disease	at	presentation,	
and	 molecular	 characteristics	 were	 all	 already	 shown	
to	 be	 prognostic	 factors	 of	 survival	 in	 patients	
with	 spinal	 ependymomas.[1‑14]	 However,	 data	 on	
postoperative	functional	status	prognosis	are	sparse.[15]	
We	 found	 that	 age,	WHO	 grade,	 and	 even	 the	 extent	
of	 the	 disease	 at	 the	 presentation	 do	 not	 correlate	
with	 postoperative	 functional	 outcome.	 The	 only	
important	 predictor	 of	 the	 functional	 outcome	 seems	
to	be	the	tumor	localization,	with	lumbar	region	being	
associated	with	 best	 results.	This	 could	 be	 due	 to	 the	
fact	 that	 complexity	 of	 surgical	 procedures	 depends	
more	 on	 the	 tumor	 localization	 than	 its	 size	 and	
histological	 type.
While	 the	histological	 tumor	 characteristics	have	been	
shown	 to	 be	 reliable	 predictors	 of	 tumor	 recurrence,	
this	 was	 not	 detected	 in	 our	 patient	 cohort.[1‑4,16]	
It	 remains	 unclear	 as	 to	 why	 this	 is	 so.	 As	 it	 was	
expected,	 the	 completeness	 of	 tumor	 resection	 was	
found	 to	 be	 the	 best	 predictor	 of	 tumor	 recurrence	 in	
our	cohort.[5‑14]
It	 is	 important	 to	 highlight	 the	 limitations	 of	 our	 study,	
among	 which	 the	 inclusion	 criteria	 manifest	 the	 most	
evident	 effects	 on	 the	 results.	A	 relatively	 small	 cohort	
size	and	the	fact	 that	 this	 is	a	single‑center	retrospective	
study	 have	 to	 be	 kept	 in	 mind	 when	 interpreting	 the	
results.
We	 would	 like	 to	 emphasize	 that	 these	 results	 were	
presented	 in	 the	 form	 of	 abstract	 at	 the	 8th	 Congress	 of	
the	Croatian	Neurosurgical	Society.
Conclusions
Surgical	 removal	 of	 spinal	 ependymomas	 remains	 the	
most	 effective	 treatment	 modality.	 Tumor	 localization	
is	 shown	 to	 have	 a	 crucial	 role	 in	 postoperative	 patient	
functional	outcome.	Therefore,	 it	 ought	 to	be	 taken	 into	
account	 when	 considering	 all	 the	 spinal	 ependymoma	
Table 1: Comparison of different parameters among 
patient groups according to early and late functional 
outcomes
Parameters Comparison among 
groups according 
to early functional 
outcomes (P)
Comparison among 
groups according 
to late functional 
outcomes (P)
Age 0.674 0.780
Gender 0.769 0.716
Number	of	
affected	vertebrae
0.726 0.126
Number	of	
affected	spinal	
regions
0.165 0.842
Histological	grade 0.309 0.873
Scope	of	surgical	
procedure
0.975 1.000
Surgical	procedure	
on	recurrent	tumor
0.582 0.204
Table 2: Comparison of different parameters among 
patient groups according to spinal ependymoma 
recurrence
Parameters Comparison among 
groups according (P)
Age 0.086
Gender 0.091
Number	of	affected	vertebrae 0.367
Number	of	affected	spinal	regions 0.476
Histological	grade 0.503
Scope	of	surgical	procedure 0.011*
*P	<	0.05
Figure 7:	Functional	status	in	a	3–6	months	follow‑up	period
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treatment	 modalities	 available.	 Further	 research	
regarding	the	optimal	treatment	protocol	is	warranted.
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